News + Filings Transactions
|
Treco Douglas A
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/08/2023 | CRISPR Therapeutics AG | CRSP | Grant | Stock Option (Right to Buy) | 13k | $62.59 | $813.7k | | 06/08/2023 |
| 04/01/2023 | Inozyme Pharma, Inc. | INZY | Grant | Restricted stock units | 100k | $0.00 | $0 | | 04/01/2023 |
| 04/01/2023 | Inozyme Pharma, Inc. | INZY | Grant | Stock option (right to buy) | 800k | $0.00 | $0 | | 04/01/2023 |
| 06/10/2022 | Inozyme Pharma, Inc. | INZY | Grant | Stock Option (right to buy) | 9.4k | $4.38 | $41k | | 06/10/2022 |
| 06/09/2022 | CRISPR Therapeutics AG | CRSP | Grant | Stock Option (Right to Buy) | 12k | $71.70 | $860.4k | | 06/09/2022 |
| 06/23/2021 | Inozyme Pharma, Inc. | INZY | Grant | Stock Option (right to buy) | 9.4k | $17.12 | $160.4k | | 06/23/2021 |
| 06/10/2021 | CRISPR Therapeutics AG | CRSP | Grant | Stock Option (Right to Buy) | 10k | $123.71 | $1.2M | | 06/10/2021 |
| 07/23/2020 | Inozyme Pharma, Inc. | INZY | Grant | Stock Option (right to buy) | 9.4k | $16.00 | $149.9k | | 07/23/2020 |
| 06/11/2020 | CRISPR Therapeutics AG | CRSP | Grant | Stock Option (Right to Buy) | 30k | $59.70 | $1.8M | | 06/11/2020 |
| 04/02/2020 | Ra Pharmaceuticals, Inc. | RARX | Disposition | Common Stock | 234.7k | $48.00 | $11.3M | | 04/02/2020 |
| 04/02/2020 | Ra Pharmaceuticals, Inc. | RARX | Disposition | Stock Option (Right to Buy) | 139.4k | $2.87 | $400k | | 04/02/2020 |
| 04/02/2020 | Ra Pharmaceuticals, Inc. | RARX | Disposition | Stock Option (Right to Buy) | 241.5k | $2.87 | $693k | | 04/02/2020 |
| 04/02/2020 | Ra Pharmaceuticals, Inc. | RARX | Disposition | Stock Option (Right to Buy) | 164.3k | $5.60 | $920k | | 04/02/2020 |
| 04/02/2020 | Ra Pharmaceuticals, Inc. | RARX | Disposition | Stock Option (Right to Buy) | 225k | $16.64 | $3.7M | | 04/02/2020 |
| 04/02/2020 | Ra Pharmaceuticals, Inc. | RARX | Disposition | Stock Option (Right to Buy) | 125k | $7.33 | $916.2k | | 04/02/2020 |
| 04/02/2020 | Ra Pharmaceuticals, Inc. | RARX | Disposition | Stock Option (Right to Buy) | 311k | $21.00 | $6.5M | | 04/02/2020 |
| 04/02/2020 | Ra Pharmaceuticals, Inc. | RARX | Disposition | Restricted Stock Units | 20.8k | $0.00 | $0 | | 04/02/2020 |
| 02/01/2019 | Ra Pharmaceuticals, Inc. | RARX | Grant | Options to Purchase Common Stock | 311k | $21.00 | $6.5M | | 02/01/2019 |
| 02/01/2019 | Ra Pharmaceuticals, Inc. | RARX | Payment of Exercise | COMMON STOCK | 6.3k | $21.00 | $132.9k | | 02/01/2019 |
| 02/01/2019 | Ra Pharmaceuticals, Inc. | RARX | Exercise | Restricted Stock Units | 20.8k | $0.00 | $0 | | 02/01/2019 |
| 02/01/2018 | Ra Pharmaceuticals, Inc. | RARX | Grant | Restricted Stock Units | 62.5k | $0.00 | $0 | | 02/01/2018 |
| 02/01/2018 | Ra Pharmaceuticals, Inc. | RARX | Grant | Options to Purchase Common Stock | 125k | $7.33 | $916.2k | | 02/01/2018 |
|